SCHEMBL20052429

SCHEMBL20052429

C=CCOC(=O)[C@@H](NC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(C)CC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 4/20 0.54
CASP1 P29466 3/20 0.54
CASP9 P55211 3/20 0.54
CASP4 P49662 1/20 0.54
CASP5 P51878 1/20 0.54
CASP6 P55212 1/20 0.54
CASP8 Q14790 1/20 0.54
CASP10 Q92851 1/20 0.54
CASP7 P55210 1/20 0.48
PSMB5 P28074 1/20 0.47
CTSB P07858 6/20 0.47
CTSK P43235 5/20 0.47
CTSL P07711 1/20 0.45
CTSS P25774 1/20 0.45
CTSD P07339 3/20 0.45
REN P00797 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15462685 1.00 CASP3 (0.54) CASP3CASP1CASP9CASP4CASP5
SCHEMBL20052381 1.00 CASP3 (0.54) CASP3CASP1CASP9CASP4CASP5
SCHEMBL20052435 0.89 CASP1 (0.56) CASP3CASP1CASP9CASP4CASP5
SCHEMBL20052390 0.89 CASP1 (0.56) CASP3CASP1CASP9CASP4CASP5
SCHEMBL15462629 0.89 CASP1 (0.56) CASP3CASP1CASP9CASP4CASP5
SCHEMBL20356179 0.88 MEN1 (0.43) CASP3CASP1CASP9CASP4CASP5
SCHEMBL7887054 0.88 CASP3 (0.51) CASP3CASP1CASP9CASP4CASP5
SCHEMBL13471019 0.87 CASP3 (0.46) CASP3CASP1CASP9CASP4CASP5
SCHEMBL12829731 0.84 CASP3 (0.48) CASP3CASP1CASP9CASP4CASP5
SCHEMBL15462622 0.84 MME (0.50) CASP3CASP1CASP9CASP4CASP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10975119-B2 Selective cysteine protease inhibitors and uses thereof GENESIS TECHNOLOGIES LIMITED (BB) 2021-04-13 US disclosed
US-20180186833-A1 SELECTIVE CYSTEINE PROTEASE INHIBITORS AND USES THEREOF GENESIS TECH LIMITED (BB) 2018-07-05 US disclosed
US-9944674-B2 Selective cysteine protease inhibitors and uses thereof GENESIS TECHNOLOGIES LIMITED (BB) 2018-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180186833-A1 SELECTIVE CYSTEINE PROTEASE INHIBITORS AND USES THEREOF SERPINB1, SERPINE1, CASP5 CASP3 146/4885CASP1 25/4885CASP9 127/4885
US-10975119-B2 Selective cysteine protease inhibitors and uses thereof SERPINB1, SERPINE1, CASP5 CASP3 171/4885CASP1 29/4885CASP9 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.